Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor loading dose formulations in stable angina before coronary angiography
2014-002227-96Phase 4Completed
- Sponsor
- Region Östergötland
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ticagrelor in angina pectoris (3 arms), sponsored by Region Östergötland. Primary endpoint: High on-treatment platelet reactivity at 20 and 60 minutes. Started Jul 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
angina pectoris
Beyond the preview
Go deeper on 2014-002227-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002227-96.